Drug-eluting coronary stents

被引：37

作者：

Salam, AM ^{[1
]}

Al Suwaidi, J ^{[1
]}

Holmes, DR ^{[1
]}

机构：

[1] Hamad Gen Hosp, Cardiac Catheterizat Lab, Doha, Qatar

来源：

CURRENT PROBLEMS IN CARDIOLOGY | 2006年 / 31卷 / 01期

关键词：

D O I：

10.1016/j.cpcardiol.2005.09.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.

引用

收藏

页码：8 / 119

页数：112

相关论文

共 369 条

[91] Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model [J].

Fishbein, I ;

Chorny, M ;

Banai, S ;

Levitzki, A ;

Danenberg, HD ;

Gao, JC ;

Chen, X ;

Moerman, E ;

Gati, I ;

Goldwasser, V ;

Golomb, G .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) :1434-1439

[92] INFLUENCE OF CORONARY VESSEL SIZE ON RENARROWING PROCESS AND LATE ANGIOGRAPHIC OUTCOME AFTER SUCCESSFUL BALLOON ANGIOPLASTY [J].

FOLEY, DP ;

MELKERT, R ;

SERRUYS, PW .

CIRCULATION, 1994, 90 (03) :1239-1251

[93] Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina [J].

Gaspardone, A ;

Crea, F ;

Versaci, F ;

Tomai, F ;

Pellegrino, A ;

Chiariello, L ;

Gioffrè, PA .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :515-+

[94] Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit [J].

Gazit, A ;

Yee, K ;

Uecker, A ;

Böhmer, FD ;

Sjöblom, T ;

Östman, A ;

Waltenberger, J ;

Golomb, G ;

Banai, S ;

Heinrich, MC ;

Levitzki, A .

BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (09) :2007-2018

[95]

Ge L, 2005, J AM COLL CARDIOL, V45, p47A

[96]

Ge L, 2005, J AM COLL CARDIOL, V45, p25A

[97] In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent [J].

Ge, L ;

Tsagalou, E ;

Iakovou, I ;

Sangiorgi, GM ;

Corvaja, N ;

Airoldi, F ;

Chieffo, A ;

Montorfano, M ;

Michev, I ;

Colombo, A .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06) :757-760

[98] Estrogen regulation of endothelial and smooth muscle cell migration and proliferation - Role of p38 and p42/44 mitogen-activated protein kinase [J].

Geraldes, P ;

Sirois, MG ;

Bernatchez, PN ;

Tanguay, JF .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1585-1590

[99] Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent - The European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial [J].

Gershlick, A ;

De Scheerder, I ;

Chevalier, B ;

Stephens-Lloyd, A ;

Camenzind, E ;

Vrints, C ;

Reifart, N ;

Missault, L ;

Goy, JJ ;

Brinker, JA ;

Raizner, AE ;

Urban, P ;

Heldman, AW .

CIRCULATION, 2004, 109 (04) :487-493

[100]

Gershlick AH, 2004, AM J CARDIOL, V94, p208E

← 5 6 7 8 9 10 11 12 13 14 →